Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/7/05 → 8/6/08 |
Funding
- Quintiles, Inc. (INCB 8721 RVT-901 // INCB 8721 RVT-901)
- Incyte Corporation (INCB 8721 RVT-901 // INCB 8721 RVT-901)
Prot# INCB 8721 RVT-901: A Long-Term Open-Label Non-Randomized Study to Evaluate the Safety of 100 and 200mg Reverset? (RVT) in HIV-Infected Antiretroviral Therapy-Experienced Subjects When Used in Combination with Other Antiretroviral Agents
- Palella Jr, Frank Joseph (PD/PI)
Project: Research project